# Momentus Inc.: financial statements, quarterly

MNTS · Nasdaq · CIK 1781162 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mnts.md) · [Financials](/companies/mnts/financials.md) · [Filings](/companies/mnts/filings.md) · [Insiders](/companies/mnts/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mnts/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.3](/filings/0001781162-24-000021.md) | [1.0 d](/filings/0001781162-25-000008.md) | [0.5](/filings/0001781162-25-000013.md) | [1.2](/filings/0001628280-25-040834.md) | [0.1](/filings/0001781162-25-000041.md) | [0.3 d](/filings/0001628280-26-022291.md) | [0.3](/filings/0001628280-26-034490.md) | [0.2](/filings/0001628280-26-055624.md) | [0.2](/filings/0001781162-25-000041.md) | [0.4 d](/filings/0001628280-26-022291.md) | [3.2](/filings/0001628280-26-034490.md) | [0.0](/filings/0001628280-26-055624.md) |
| Cost of revenue | $m | [0.1](/filings/0001781162-24-000021.md) | [0.3 d](/filings/0001781162-25-000008.md) | not reported | [0.0](/filings/0001628280-25-040834.md) | [0.1](/filings/0001781162-25-000041.md) | [0.0 d](/filings/0001628280-26-022291.md) | [0.0](/filings/0001628280-26-034490.md) | [0.0](/filings/0001628280-26-055624.md) | [0.0](/filings/0001781162-25-000041.md) | [0.0 d](/filings/0001628280-26-022291.md) | [1.4](/filings/0001628280-26-034490.md) | [0.0](/filings/0001628280-26-055624.md) |
| Gross profit | $m | [0.2](/filings/0001781162-24-000021.md) | [0.7 d](/filings/0001781162-25-000008.md) | [0.5](/filings/0001781162-25-000013.md) | [1.2](/filings/0001628280-25-040834.md) | [0.0](/filings/0001781162-25-000041.md) | [0.3 d](/filings/0001628280-26-022291.md) | [0.3](/filings/0001628280-26-034490.md) | [0.2](/filings/0001628280-26-055624.md) | [0.2](/filings/0001781162-25-000041.md) | [0.4 d](/filings/0001628280-26-022291.md) | [1.8](/filings/0001628280-26-034490.md) | [0.0](/filings/0001628280-26-055624.md) |
| Research and development | $m | [6.0](/filings/0001781162-24-000021.md) | [8.0 d](/filings/0001781162-25-000008.md) | [2.7](/filings/0001781162-25-000013.md) | [2.9](/filings/0001628280-25-040834.md) | [2.2](/filings/0001781162-25-000041.md) | [2.1 d](/filings/0001628280-26-022291.md) | [1.9](/filings/0001628280-26-034490.md) | [2.2](/filings/0001628280-26-055624.md) | [2.3](/filings/0001781162-25-000041.md) | [2.8 d](/filings/0001628280-26-022291.md) | [4.2](/filings/0001628280-26-034490.md) | [4.2](/filings/0001628280-26-055624.md) |
| Selling, general and administrative | $m | [9.3](/filings/0001781162-24-000021.md) | [6.5 d](/filings/0001781162-25-000008.md) | [6.2](/filings/0001781162-25-000013.md) | [5.3](/filings/0001628280-25-040834.md) | [5.4](/filings/0001781162-25-000041.md) | [5.0 d](/filings/0001628280-26-022291.md) | [4.6](/filings/0001628280-26-034490.md) | [3.9](/filings/0001628280-26-055624.md) | [4.2](/filings/0001781162-25-000041.md) | [6.5 d](/filings/0001628280-26-022291.md) | [6.3](/filings/0001628280-26-034490.md) | [3.9](/filings/0001628280-26-055624.md) |
| Operating income | $m | [(15.1)](/filings/0001781162-24-000021.md) | [(13.8) d](/filings/0001781162-25-000008.md) | [(8.3)](/filings/0001781162-25-000013.md) | [(7.0)](/filings/0001628280-25-040834.md) | [(7.6)](/filings/0001781162-25-000041.md) | [(6.8) d](/filings/0001628280-26-022291.md) | [(6.2)](/filings/0001628280-26-034490.md) | [(5.9)](/filings/0001628280-26-055624.md) | [(6.2)](/filings/0001781162-25-000041.md) | [(8.9) d](/filings/0001628280-26-022291.md) | [(8.7)](/filings/0001628280-26-034490.md) | [(8.1)](/filings/0001628280-26-055624.md) |
| Interest expense | $m | [0.5](/filings/0001781162-23-000059.md) | [0.2 d](/filings/0001628280-24-026929.md) | [0.1](/filings/0001781162-25-000013.md) | [0.0](/filings/0001628280-25-040834.md) | [0.0](/filings/0001781162-25-000041.md) | [0.3 d](/filings/0001628280-26-022291.md) | [(0.2)](/filings/0001628280-26-034490.md) | [0.1](/filings/0001628280-26-055624.md) | [0.2](/filings/0001781162-25-000041.md) | [0.6 d](/filings/0001628280-26-022291.md) | [0.6](/filings/0001628280-26-034490.md) | [0.1](/filings/0001628280-26-055624.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(15.2)](/filings/0001781162-24-000021.md) | [(14.1) d](/filings/0001781162-25-000008.md) | [(8.3)](/filings/0001781162-25-000041.md) | [(7.0)](/filings/0001781162-25-000041.md) | [(7.8)](/filings/0001781162-25-000041.md) | [(11.9) d](/filings/0001628280-26-022291.md) | [(6.2)](/filings/0001628280-26-055624.md) | [(6.5)](/filings/0001628280-26-055624.md) | [(11.1)](/filings/0001781162-25-000041.md) | [(6.8) d](/filings/0001628280-26-022291.md) | [(9.5)](/filings/0001628280-26-055624.md) | [(8.3)](/filings/0001628280-26-055624.md) |
| Diluted EPS | $ per share | [(7.20)](/filings/0001781162-24-000021.md) | not reported | [(9.25)](/filings/0001781162-25-000013.md) | [(5.92)](/filings/0001628280-25-040834.md) | [(6.26)](/filings/0001781162-25-000041.md) | not reported | [(29.29)](/filings/0001628280-26-034490.md) | [(22.03)](/filings/0001628280-26-055624.md) | [(1.08)](/filings/0001781162-25-000041.md) | not reported | [(2.15)](/filings/0001628280-26-034490.md) | [(0.70)](/filings/0001628280-26-055624.md) |
| Basic EPS | $ per share | [(7.20)](/filings/0001781162-24-000021.md) | not reported | [(9.25)](/filings/0001781162-25-000013.md) | [(5.92)](/filings/0001628280-25-040834.md) | [(6.26)](/filings/0001781162-25-000041.md) | not reported | [(29.29)](/filings/0001628280-26-034490.md) | [(22.03)](/filings/0001628280-26-055624.md) | [(1.08)](/filings/0001781162-25-000041.md) | not reported | [(2.15)](/filings/0001628280-26-034490.md) | [(0.70)](/filings/0001628280-26-055624.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [9.8](/filings/0001781162-23-000059.md) | [2.1](/filings/0001781162-25-000008.md) | [1.7](/filings/0001781162-24-000009.md) | [0.9](/filings/0001781162-24-000010.md) | [0.8](/filings/0001781162-24-000021.md) | [1.6](/filings/0001628280-26-022291.md) | [3.4](/filings/0001781162-25-000013.md) | [0.1](/filings/0001628280-25-040834.md) | [0.7](/filings/0001781162-25-000041.md) | [12.8](/filings/0001628280-26-055624.md) | [23.5](/filings/0001628280-26-034490.md) | [108](/filings/0001628280-26-055624.md) |
| Current assets | $m | [21.2](/filings/0001781162-23-000059.md) | [10.7](/filings/0001781162-25-000008.md) | [9.3](/filings/0001781162-24-000009.md) | [6.2](/filings/0001781162-24-000010.md) | [5.4](/filings/0001781162-24-000021.md) | [4.5](/filings/0001628280-26-022291.md) | [6.8](/filings/0001781162-25-000013.md) | [4.3](/filings/0001628280-25-040834.md) | [7.1](/filings/0001781162-25-000041.md) | [22.3](/filings/0001628280-26-055624.md) | [29.3](/filings/0001628280-26-034490.md) | [113](/filings/0001628280-26-055624.md) |
| Total assets | $m | [33.5](/filings/0001781162-23-000059.md) | [20.6](/filings/0001781162-25-000008.md) | [18.7](/filings/0001781162-24-000009.md) | [15.0](/filings/0001781162-24-000010.md) | [14.1](/filings/0001781162-24-000021.md) | [10.0](/filings/0001628280-26-022291.md) | [11.7](/filings/0001781162-25-000013.md) | [9.2](/filings/0001628280-25-040834.md) | [19.6](/filings/0001781162-25-000041.md) | [40.3](/filings/0001628280-26-055624.md) | [45.9](/filings/0001628280-26-034490.md) | [130](/filings/0001628280-26-055624.md) |
| Current liabilities | $m | [23.1](/filings/0001781162-23-000059.md) | [11.1](/filings/0001781162-25-000008.md) | [9.6](/filings/0001781162-24-000009.md) | [11.5](/filings/0001781162-24-000010.md) | [14.0](/filings/0001781162-24-000021.md) | [15.0](/filings/0001628280-26-022291.md) | [17.0](/filings/0001781162-25-000013.md) | [19.0](/filings/0001628280-25-040834.md) | [17.3](/filings/0001781162-25-000041.md) | [16.1](/filings/0001628280-26-055624.md) | [11.6](/filings/0001628280-26-034490.md) | [8.3](/filings/0001628280-26-055624.md) |
| Total liabilities | $m | [29.2](/filings/0001781162-23-000059.md) | [17.5](/filings/0001781162-25-000008.md) | [15.3](/filings/0001781162-24-000009.md) | [16.8](/filings/0001781162-24-000010.md) | [19.5](/filings/0001781162-24-000021.md) | [17.8](/filings/0001628280-26-022291.md) | [17.7](/filings/0001781162-25-000013.md) | [19.2](/filings/0001628280-25-040834.md) | [20.3](/filings/0001781162-25-000041.md) | [23.2](/filings/0001628280-26-055624.md) | [18.7](/filings/0001628280-26-034490.md) | [15.3](/filings/0001628280-26-055624.md) |
| Shareholders' equity | $m | [4.3](/filings/0001781162-24-000021.md) | [3.2](/filings/0001628280-26-022291.md) | [3.5](/filings/0001781162-25-000041.md) | [(1.8)](/filings/0001781162-25-000041.md) | [(5.4)](/filings/0001781162-25-000041.md) | [(7.8)](/filings/0001628280-26-055624.md) | [(6.0)](/filings/0001628280-26-055624.md) | [(10.0)](/filings/0001628280-26-055624.md) | [(0.7)](/filings/0001781162-25-000041.md) | [17.1](/filings/0001628280-26-055624.md) | [27.2](/filings/0001628280-26-055624.md) | [114](/filings/0001628280-26-055624.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(12.8) d](/filings/0001781162-24-000021.md) | [(15.8) d](/filings/0001781162-25-000008.md) | [(5.3)](/filings/0001781162-25-000013.md) | [(1.1) d](/filings/0001628280-25-040834.md) | [(4.5) d](/filings/0001781162-25-000041.md) | [(5.7) d](/filings/0001628280-26-022291.md) | [(4.2)](/filings/0001628280-26-034490.md) | [(3.2) d](/filings/0001628280-26-055624.md) | [(5.3) d](/filings/0001781162-25-000041.md) | [(10.5) d](/filings/0001628280-26-022291.md) | [(5.8)](/filings/0001628280-26-034490.md) | [(9.1) d](/filings/0001628280-26-055624.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001781162-24-000021.md) | [0.0 d](/filings/0001781162-25-000008.md) | [0.0](/filings/0001781162-24-000009.md) | [0.0 d](/filings/0001781162-24-000010.md) | [0.0 d](/filings/0001781162-24-000021.md) | [0.0 d](/filings/0001628280-26-022291.md) | [0.0](/filings/0001628280-26-034490.md) | [0.0 d](/filings/0001628280-26-055624.md) | not reported | not reported | [0.2](/filings/0001628280-26-034490.md) | [0.0 d](/filings/0001628280-26-055624.md) |
| Share repurchases | $m | [0.0 d](/filings/0001781162-24-000021.md) | [0.0 d](/filings/0001781162-25-000008.md) | [0.0](/filings/0001781162-24-000009.md) | [0.0 d](/filings/0001781162-24-000010.md) | [0.0 d](/filings/0001781162-24-000021.md) | [0.0 d](/filings/0001781162-25-000008.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1.6](/filings/0001781162-23-000059.md) | [1.8](/filings/0001781162-24-000009.md) | [1.9](/filings/0001781162-24-000010.md) | [2.1](/filings/0001781162-24-000021.md) | [0.9](/filings/0001781162-25-000013.md) | [1.2](/filings/0001628280-25-040834.md) | [1.2](/filings/0001781162-25-000041.md) | [0.2](/filings/0001628280-26-034490.md) | [0.3](/filings/0001628280-26-055624.md) | [10.3](/filings/0001781162-25-000041.md) | [4.4](/filings/0001628280-26-034490.md) | [11.9](/filings/0001628280-26-055624.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 21,963,401 at 2026-08-10, from the cover of the [10-Q filed 2026-08-11](/filings/0001628280-26-055624.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.